(Q70136320)

English

In-vitro susceptibility of cefoperazone-susceptible and -resistant gram-negative rods to cefoperazone plus sulbactam, other beta-lactams, aminoglycosides and quinolone

scientific article published on 01 January 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2013510%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

In-vitro susceptibility of cefoperazone-susceptible and -resistant gram-negative rods to cefoperazone plus sulbactam, other beta-lactams, aminoglycosides and quinolone (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2013510%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

author name string

P H Chandrasekar

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2013510%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

J A Sluchak

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2013510%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

publication date

1 January 1991

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2013510%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2013510%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2013510%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2013510%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

49-53

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2013510%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

https://scigraph.springernature.com/pub.10.1007/bf01643761

0 references

Bacterial resistance to fluoroquinolones

1 reference

https://pubmed.ncbi.nlm.nih.gov/2013510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of β-lactamase inhibitors in combination with new β-lactam antibiotics against resistant gram-negative organisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/2013510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro antimicrobial activity of cefoperazone-sulbactam combinations against 554 clinical isolates including a review and beta-lactamase studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/2013510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of sulbactam in combination with various beta-lactam antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/2013510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2013510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic activity of cefoperazone in combination with β-lactamase inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2013510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of sulbactam/cefoperazone for the treatment of infections in patients with hematologic diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/2013510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concept of empiric therapy with antibiotic combinations. Indications and limits

1 reference

https://pubmed.ncbi.nlm.nih.gov/2013510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro assessment of sulbactam plus cefoperazone in the treatment of bacteria isolated from cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2013510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2013510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy for lower respiratory tract infections with imipenem/cilastatin: a review of worldwide experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/2013510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2013510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01643761

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2013510%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2013510%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q70136320&oldid=2145258388"